Wegovy, Ozempic maker Novo Nordisk Q3 earnings

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish pharmaceutical giant Novo Nordisk said Wednesday it is lowering its growth expectations for its key obesity and diabetes treatments. Net profit for the quarter came in at 20 billion Danish kroner ($3.1 billion) in line…

Read More